Clinical improvement of ocular surface parameters in dry eye patients following treatment with urea/crosslinked-hyaluronate eyedrops correlates with the secretion of MUC-4

References

• Craig JP, Nichols KK, and Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–283.
   PubMed Web of Science ®Google Scholar
• Shimazaki J. Definition and diagnostic criteria of dry eye disease: historical overview and future directions. Invest Ophthalmol Vis Sci. 2018;59:DES7–DES12.
   PubMed Web of Science ®Google Scholar
• International Dry Eye Workshop. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75–92.
   PubMed Web of Science ®Google Scholar
• Fallacara A, Vertuani S, Panozzo G, et al. Novel artificial tears containing cross-linked hyaluronic acid: an in vitro re-epithelialization study. Molecules. 2017;22. DOI:https://doi.org/10.3390/molecules22122104.
   Google Scholar
• Fallacara A, Busato L, Pozzoli M, et al. Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: an in vitro study. Eur J Pharm Sci. 2018;120:96–106.
   PubMed Web of Science ®Google Scholar
• Charlton JF, Schwab IR, Stuchell R. Topical urea as a treatment for non-infectious keratopathy. Acta Ophthalmol Scand. 1996;74:391–394.
   PubMedGoogle Scholar
• Choudhury A, Dey M, Dixit HN, et al. Tear-film breakup: the role of membrane-associated mucin polymers. Phys Rev E. 2021;103:013108.
   PubMed Web of Science ®Google Scholar
• Corrales RM, Narayanan S, Fernández I, et al. Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. Invest Ophthalmol Vis Sci. 2011;52:8363–8369.
   PubMed Web of Science ®Google Scholar
• Dartt DA. Control of mucin production by ocular surface epithelial cells. Exp Eye Res. 2004;78:173–185.
   PubMed Web of Science ®Google Scholar
• Gipson IK, Hori Y, and Argüeso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf. 2004;2:131–148.
   PubMedGoogle Scholar
• Nakamura M, Hikida M, Nakano T, et al. Characterization of water retentive properties of hyaluronan. Cornea. 1993;12:433–436.
   PubMed Web of Science ®Google Scholar
• Pinto-Bonilla JC, Del Olmo-Jimeno A, Llovet-Osuna F, et al. A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome. Ther Clin Risk Manag. 2015;11:595–603.
   PubMed Web of Science ®Google Scholar
• Posarelli C, Passani A, Del Re M, et al. Cross-linked hyaluronic acid as tear film substitute. J Ocul Pharmacol Ther. 2019;35:381–387.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118:615–621.
   PubMed Web of Science ®Google Scholar
• De Monchy I, Gendron G, Miceli C, et al. Combination of the Schirmer I and phenol red thread tests as a rescue strategy for diagnosis of ocular dryness associated with Sjögren’s syndrome. Invest Ophthalmol Vis Sci. 2011;52:5167–5173.
   PubMed Web of Science ®Google Scholar
• Mengher LS, Bron AJ, Tonge SR, et al. A non-invasive instrument for clinical assessment of the pre-corneal tear film stability. Curr Eye Res. 1985;4:1–7.
   PubMed Web of Science ®Google Scholar
• Lemp MA. Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221–232.
   PubMedGoogle Scholar
• van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82:10–14.
   PubMed Web of Science ®Google Scholar
• Singh R, Joseph A, Umapathy T, et al. Impression cytology of the ocular surface. Br J Ophthalmol. 2005;89:1655–1659.
   PubMed Web of Science ®Google Scholar
• Perkins DN, Pappin DJ, Creasy DM, et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20:3551–3567.
   PubMed Web of Science ®Google Scholar
• Gomes JA, Amankwah R, Powell-Richards A, et al. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol. 2004;88:821–825.
   PubMed Web of Science ®Google Scholar
• Fallacara A, Busato L, Pozzoli M, et al. In vitro characterization of physico-chemical properties, cytotoxicity, bioactivity of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation. Int J Pharm. 2019;558:341–350.
   PubMedGoogle Scholar
• Ang BCH, Sng JJ, and Wang PXH, et al. Sodium hyaluronate in the treatment of dry eye syndrome: a systematic review and meta-analysis. Sci Rep. 2017;7:9013.
   PubMed Web of Science ®Google Scholar
• Aragona P, Papa V, Micali A, et al. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol. 2002;86:181–184.
   PubMed Web of Science ®Google Scholar
• Szegedi S, Scheschy U, Schmidl D, et al. Effect of single instillation of two hyaluronic acid-based topical lubricants on tear film thickness in patients with dry eye syndrome. J Ocul Pharmacol Ther. 2018;34:605–611.
   PubMed Web of Science ®Google Scholar
• Doan S, Bremond-Gignac D, Chiambaretta F. Comparison of the effect of a hyaluronate-trehalose solution to hyaluronate alone on ocular surface disease index in patients with moderate to severe dry eye disease. Curr Med Res Opin. 2018;34:1373–1376.
   PubMed Web of Science ®Google Scholar
• Cagini C, Torroni G, Fiore T, et al. Tear film stability in Sjögren syndrome patients treated with hyaluronic acid versus crosslinked hyaluronic acid-based eye drops. J Ocul Pharmacol Ther. 2017;33:539–542.
   PubMed Web of Science ®Google Scholar
• Inoue M, Katakami C. The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest Ophthalmol Vis Sci. 1993;34:2313–2315.
   PubMed Web of Science ®Google Scholar
• Prabhasawat P, Tesavibul N, Kasetsuwan N. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study. Br J Ophthalmol. 2007;91:47–50.
   PubMed Web of Science ®Google Scholar
• Jeong CH, Kim DH, Yune JH, et al. In vitro toxicity assessment of crosslinking agents used in hyaluronic acid dermal filler. Toxicol In Vitro. 2021;70:105034.
   PubMed Web of Science ®Google Scholar
• Lai JY. Relationship between structure and cytocompatibility of divinyl sulfone cross-linked hyaluronic acid. Carbohydr Polym. 2014;101:203–212.
   PubMed Web of Science ®Google Scholar
• Postorino EI, Rania L, Aragona E, et al. Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye. Eur J Ophthalmol. 2018;28:25–31.
   PubMed Web of Science ®Google Scholar
• Williams DL, Mann BK. A crosslinked HA-based hydrogel ameliorates dry eye symptoms in dogs. Int J Biomater. 2013;2013:460437.
   PubMedGoogle Scholar
• Williams DL. Optimising tear replacement rheology in canine keratoconjunctivitis sicca. Eye (Lond). 2018;32:195–199.
   PubMed Web of Science ®Google Scholar
• Williams DL, Mann BK. Efficacy of a crosslinked hyaluronic acid-based hydrogel as a tear film supplement: a masked controlled study. PLoS One. 2014;9:e99766.
   PubMed Web of Science ®Google Scholar
• Tredici C, Fasciani R, Villano A, et al. Efficacy of eye drops containing crosslinked hyaluronic acid and CoQ10 in restoring ocular health exposed to chlorinated water. Eur J Ophthalmol. 2020;30:430–438.
   PubMed Web of Science ®Google Scholar
• Sánchez-González JM, De-Hita-Cantalejo C, Sánchez-González MC. Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction. Int J Ophthalmol. 2020;13:1368–1373.
   PubMed Web of Science ®Google Scholar